Lirui Wang

639 Longmian Avenue
Nanjing, 211198, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications

Intestinal REG3 Lectins Protect against Alcoholic Steatohepatitis by Reducing Mucosa-Associated Microbiota and Preventing Bacterial Translocation.

Intestinal REG3 Lectins Protect against Alcoholic Steatohepatitis by Reducing Mucosa-Associated Microbiota and Preventing Bacterial Translocation.

Journal: Cell host & microbe
Published: October 18, 2025

Hepatocyte CHRNA4 mediates the MASH-promotive effects of immune cell-produced acetylcholine and smoking exposure in mice and humans.

Hepatocyte CHRNA4 mediates the MASH-promotive effects of immune cell-produced acetylcholine and smoking exposure in mice and humans.

Journal: Cell metabolism
Published: June 21, 2023

Alcohol drinking alters oral microbiota to modulate the progression of alcohol-related liver disease.

Alcohol drinking alters oral microbiota to modulate the progression of alcohol-related liver disease.

Journal: iScience
Published: March 20, 2023

Association between iron metabolism and non-alcoholic fatty liver disease: results from the National Health and Nutrition Examination Survey (NHANES 2017-2018) and a controlled animal study.

Association between iron metabolism and non-alcoholic fatty liver disease: results from the National Health and Nutrition Examination Survey (NHANES 2017-2018) and a controlled animal study.

Journal: Nutrition & metabolism
Published: September 03, 2022

Amlodipine, an anti-hypertensive drug, alleviates non-alcoholic fatty liver disease by modulating gut microbiota.

Amlodipine, an anti-hypertensive drug, alleviates non-alcoholic fatty liver disease by modulating gut microbiota.

Journal: British journal of pharmacology
Published: May 27, 2021

Aryl Hydrocarbon Receptor Deficiency in Intestinal Epithelial Cells Aggravates Alcohol-Related Liver Disease.

Aryl Hydrocarbon Receptor Deficiency in Intestinal Epithelial Cells Aggravates Alcohol-Related Liver Disease.

Journal: Cellular and molecular gastroenterology and hepatology
Published: November 19, 2020

Intestinal α1-2-Fucosylation Contributes to Obesity and Steatohepatitis in Mice.

Intestinal α1-2-Fucosylation Contributes to Obesity and Steatohepatitis in Mice.

Journal: Cellular and molecular gastroenterology and hepatology
Published: April 17, 2020

A systematic metabolic pathway identification of Common Gardenia Fruit (Gardeniae Fructus) in mouse bile, plasma, urine and feces by HPLC-Q-TOF-MS/MS.

A systematic metabolic pathway identification of Common Gardenia Fruit (Gardeniae Fructus) in mouse bile, plasma, urine and feces by HPLC-Q-TOF-MS/MS.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
Published: February 21, 2020

YIPF6 controls sorting of FGF21 into COPII vesicles and promotes obesity.

YIPF6 controls sorting of FGF21 into COPII vesicles and promotes obesity.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 11, 2019

WZ66, a novel acetyl-CoA carboxylase inhibitor, alleviates nonalcoholic steatohepatitis (NASH) in mice.

WZ66, a novel acetyl-CoA carboxylase inhibitor, alleviates nonalcoholic steatohepatitis (NASH) in mice.

Journal: Acta pharmacologica Sinica
Published: June 18, 2019

Chitosan Oligosaccharide Ameliorates Nonalcoholic Fatty Liver Disease (NAFLD) in Diet-Induced Obese Mice.

Chitosan Oligosaccharide Ameliorates Nonalcoholic Fatty Liver Disease (NAFLD) in Diet-Induced Obese Mice.

Journal: Marine drugs
Published: June 08, 2019

Intestinal and hepatic microbiota changes associated with chronic ethanol administration in mice.

Intestinal and hepatic microbiota changes associated with chronic ethanol administration in mice.

Journal: Gut microbes
Published: April 16, 2019
Showing 1-12 of 30

Last Updated: 09/26/2026